ArticleLancet regional health. Americas2024
Effects of the Communities that Heal (CTH) intervention on perceived opioid-related community stigma in the HEALing Communities Study: results of a multi-site, community-level, cluster-randomized trial.
Article in Lancet regional health. Americas, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 15 citations in OpenAlex.
- Cost of implementing evidence-based practices to reduce opioid overdose fatalities in New York State communities.Addiction science & clinical practice · 2025Trial
- The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial.The International journal on drug policy · 2025Trial
- Description of implementing a mail-based overdose education and naloxone distribution program in community supervision settings during COVID-19.Journal of substance use and addiction treatment · 2025Trial
- A digital citizen science intervention to reduce HIV stigma and promote HIV testing: a randomized clinical trial among adolescents and young adults in Kazakhstan.Sexual health · 2025Trial
- Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial.JAMA network open · 2024Trial
- Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (Helping End Addiction Long-Term®) communities study.Preventive medicine · 2024Trial
- Examining the factors associated with sustaining jail-based programs linking to community-based Medication for Opioid User Disorder (MOUD) treatment.Health & justice · 2026Article
- Telehealth and Intervention Stigma: Patient Perspectives About Flexible Opioid Use Disorder Treatment Delivery.Substance use & addiction journal · 2026Article
- Examining the Factors Associated with Sustaining Jail-based Programs Linking to Community-based Medication for Opioid User Disorder (MOUD) Treatment.Research square · 2026Article
- Stakeholder-informed recommendations for patient-centered medication service delivery for stimulant use disorder: a qualitative study.Addiction science & clinical practice · 2026Article
- The role of external and internal context on adoption and implementation of evidence-based practices: a serial case study qualitative analysis of top performers in the HEALing Communities Study.Implementation science communications · 2026Article
- Article
- Strategies to Facilitate Interorganizational Collaboration in County-Level Opioid Overdose Prevention and Response: A Qualitative Analysis.International journal of environmental research and public health · 2025Article
- A scoping review of interventions addressing social determinants of health and their influence on opioid use disorder outcomes.Drug and alcohol dependence · 2025Article
- The Digital Divide and Tele-MOUD: A Qualitative Study of Opioid Community Coalition Perspectives During COVID-19.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2025Article
- A mixed-method exploratory assessment of provider-based stigma of opioid use disorder (OUD) and support for medications for opioid use disorder (MOUD) in carceral settings.Harm reduction journal · 2025Article
- The wide-angle lens of implementation science to improve health outcomes in criminal legal settings.Health & justice · 2025Review
- Solving the "last mile" problem in overdose prevention: Lessons from the HEALing Communities Study.Drug and alcohol dependence · 2024Article
- Collaboration with community partners to expand naloxone access in the HEALing Communities Study.Journal of the American Pharmacists Association : JAPhAArticle
- Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings.Journal of addiction medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors at 9 institutions in 1 country.
Funding
Abstract
Background: Community stigma against people with opioid use disorder (OUD) and intervention stigma (e.g., toward naloxone) exacerbate the opioid overdose crisis. We examined the effects of the Communities that HEAL (CTH) intervention on perceived opioid-related community stigma by stakeholders in the HEALing Communities Study (HCS). Methods: We collected three surveys from community coalition members in 66 communities across four states participating in HCS. Communities were randomized into Intervention (Wave 1) or Wait-list Control (Wave 2) arms. We conducted multilevel linear mixed models to compare changes in primary outcomes of community stigma toward people treated for OUD, naloxone, and medication for opioid use disorder (MOUD) by arm from time 1 (before the start of the intervention) to time 3 (end of the intervention period in the Intervention arm). Findings: Intervention stakeholders reported a larger decrease in perceived community stigma toward people treated for OUD (adjusted mean change (AMC) -3.20 [95% C.I. -4.43, -1.98]) and toward MOUD (AMC -0.33 [95% C.I. -0.56, -0.09]) than stakeholders in Wait-list Control communities (AMC -0.18 [95% C.I. -1.38, 1.02], Interpretation: The CTH intervention decreased stakeholder perceptions of community stigma toward people treated for OUD and stigma toward MOUD. Implementing the CTH intervention in other communities could decrease OUD stigma across diverse settings nationally. Funding: US National Institute on Drug Abuse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.